Navigation Links
PPD Reports Fourth Quarter and Year-End 2007 Financial Results
Date:2/6/2008

, cash equivalents and short-term investments, and no long term debt.

"PPD closed out 2007 with a solid finish in Q4 as evidenced by strong bookings, an exceptional book-to-bill ratio and a backlog of $2.65 billion," said Fred Eshelman, chief executive officer of PPD. "With this finish and our new senior management team in place, our development business is positioned for solid performance in 2008. In addition, with the advancement of several of our compound collaborations, including Takeda's submission of the alogliptin NDA in late December, we are particularly excited about the potential maturation of our compound partnering business".

PPD will conduct a live conference call and audio webcast tomorrow, February 7, 2008, at 9:00 a.m. EST to discuss fourth quarter and 2007 year-end results. A Q&A session will follow. To access the webcast, please visit http://www.ppdi.com and follow the directions under the Investor Presentations & Events link in the Corporate section of the PPD Web site. A replay of the webcast will be available shortly after the call. The conference call will be broadcast live over the Internet, and the live call may be accessed via the following direct dial numbers:

Participant toll free dial in: +877 644 0692

Conference ID: 30076135

PPD is a leading global contract research organization providing discovery, development and post-approval services as well as compound partnering programs. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 30 countries and more than 10,200 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help its clients and partners maximize returns on their R&D investments and accelerate the delivery of safe and effective therapeutics to patients. For more information, visit our Web site at

SOURCE PPD, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... 17 Today, CDC,s Morbidity and Mortality ... the number of state-level epidemiologists has decreased steadily ... 10% since 2006. There was also a substantial ... period, including epidemiology capacity for bioterrorism and emergency ... such as occupational health, substance abuse, and oral ...
(Date:12/17/2009)... /PRNewswire-Asia/ -- China,s leading high-tech,healthcare group, Golden Meditech ... 801) is pleased to announce today the interim ... review, the Group,s two,associate companies made their debut ... key businesses have been strengthened, with maiden revenue ... , Mr. KAM Yuen, ...
(Date:12/17/2009)... 2009 Canadian teenagers are among the largest consumers ... drug on young brains are worse than originally thought, ... psychiatric researcher from the Research Institute of the McGill ... Neurobiology of Disease , suggests that daily consumption of ... have an irreversible long-term effect on the brain. , ...
(Date:12/17/2009)... clients Rutherford Hospital Inc. (Rutherfordton, N.C.), a management client ... client since 1992, were recently recognized as top-ranked Community ... ... Brentwood, Tenn. (PRWEB) December ... Hospital Inc. (Rutherfordton, N.C.), a management client since 1983, ...
(Date:12/17/2009)... primary care doctors who agree to BCBSNC’s standard contract. Physicians ... services, , ... Chapel Hill, NC ... Shield of North Carolina (BCBSNC) is leading an effort ... a new reimbursement model for participating primary care physicians., , ...
Breaking Medicine News(10 mins):Health News:CSTE National Assessment Finds Critical Public Health Disease Surveillance Capacity Lacking 2Health News:Golden Meditech Announces Interim Results of FY2009/10 2Health News:Golden Meditech Announces Interim Results of FY2009/10 3Health News:QHR Client Hospitals in North Carolina, Michigan Lauded for Providing Community Value 2Health News:BCBSNC Rewarding Physicians for Better Care, Not More Care, Through Blue Quality Physician Program, 2Health News:BCBSNC Rewarding Physicians for Better Care, Not More Care, Through Blue Quality Physician Program, 3
... Hodgkins Lymphoma should be especially vigilant about cancer ... Forest University Baptist Medical Center and colleagues. , ... Society of Clinical Oncology in Chicago today, Sharon ... study of 1,927 Hodgkins survivors found that treatments ...
... female survivors; cardiovascular events for males , , SATURDAY, ... lymphoma as children have an increased risk of developing ... adults, according to a new report. , The ... help drive these increased risks, according to the researchers. ...
... a randomized, controlled trial found that acupuncture provided significant ... and neck cancer patients after neck dissection. The study ... Head and Neck Medical Oncology Service, and Barrie Cassileth, ... Sloan-Kettering Cancer Center (MSKCC). Dr. Pfister presented the findings ...
... diminished ovarian reserve producing viable eggs, study suggests ... may reduce fertility in breast cancer survivors, according ... Dana-Farber Cancer Institute. , They found that premenopausal ... were more likely than women who,d never had ...
... born neuronal stem cells in the adult brain may provide ... are to be utilized in this way, the process by ... A new study, led by Laurence Katz, Co-Director of the ... Carolina School of Medicine, suggests a way in which this ...
... SAN CLEMENTE, Calif., May 30 Hero Nutritionals,introduced Slice ... adults, at,the Natural Products Expo West in March 2008. ... Coenzyme Q10. Though CoQ10 is found in every cell ... from the word,ubiquitous for ,found everywhere, low levels of ...
Other Medicine News:Health News:Survivors of childhood Hodgkin's lymphoma at higher risk of future health problems 2Health News:Hodgkin Lymphoma Kids Face Greater Risk of Future Problems 2Health News:Acupuncture reduces pain and dysfunction in head and neck cancer patients after neck dissection 2Health News:Chemo May Limit Fertility in Breast Cancer Survivors 2
(Date:12/16/2009)... Dec. 16 DATATRAK International, Inc. ... focused on global eClinical solutions for the ... of its version 9.0 eClinical Software. ... for product and service delivery and introduces ... Knowledge(TM) offering: the DATATRAK Learning Center(TM) and ...
(Date:12/16/2009)... 16 HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA) ... secured $1 million in 12% per annum short term ... is an initial drawdown of $500,000, with accrued interest ... of $500,000 with accrued interest and principal repayable in ... Company becoming cashflow positive for any calendar month prior ...
(Date:12/16/2009)... -- Scientists at,deCODE genetics, Inc. (Nasdaq: DCGN ) ... version of a common single-letter variant in the ... impact on susceptibility to type 2,diabetes (T2D). The ... large, but unusual:,if an individual inherits it from ... more than 30% compared to those who inherit ...
Breaking Medicine Technology:DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4Children 26apos 3Bs National Experts Presenting at American Academy of Pediatrics Conference 0A 59675 1Children 26apos 3Bs National Experts Presenting at American Academy of Pediatrics Conference 0A 59675 2Chicago Veterinary Emergency Services Goes 24 7 for Emergency Care 59672 1Chicago Veterinary Emergency Services Goes 24 7 for Emergency Care 59672 2Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 1Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 2Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 3Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 4Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 5Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 6Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 7Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 8Enbrel 28R 29 28etanercept 29 Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 59669 9
... in severely-injured, acute ... HOPKINTON, Mass., May 12 Alseres,Pharmaceuticals, Inc. (Nasdaq: ... I/IIa clinical trial of Cethrin, a proprietary recombinant,protein that ... and,sensory function after spinal cord injury, or SCI. The ...
... 12 GlaxoSmithKline (GSK),in collaboration with the Breast ... network, and one of its member groups, the,Spanish ... start,of a global Phase III study that will ... early breast cancer. Neo-ALTTO (Neoadjuvant Lapatinib and/or,Trastuzumab Treatment ...
Other Medicine Technology:Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 2Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 3Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 4Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 2TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 3TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 4TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 6TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 7
... Prostate Stepper Template Set is the HDR ... seed implantation technique. The template set consists ... can be sutured to the patient and ... variable ultrasound Grid Face Plates. The Stepper ...
... Reusable Template is designed for use ... system for prostate brachytherapy. Please be ... software match the graphics on the ... pins protruding from lower surface which ...
Table mount stabilizer system...
The compact PT stepper is lightweight, user-friendly, and versatile. The perfect solution for a busy brachytherapy facility....
Medicine Products: